Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
128.13
+1.25 (0.99%)
Apr 14, 2025, 2:28 PM EDT - Market open
Abbott Laboratories Employees
Abbott Laboratories had 114,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
114,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
222.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 114,000 | 0 | - |
Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
Dec 31, 2012 | 91,000 | 0 | - |
Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
Dec 31, 2005 | 59,735 | -865 | -1.43% |
Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
Dec 31, 2003 | 72,200 | 381 | 0.53% |
Dec 31, 2002 | 71,819 | 393 | 0.55% |
Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
Dec 31, 1999 | 57,100 | 864 | 1.54% |
Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
Dec 31, 1995 | 50,241 | 777 | 1.57% |
Dec 31, 1994 | 49,464 | -195 | -0.39% |
Dec 31, 1993 | 49,659 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Thermo Fisher Scientific | 125,000 |
AstraZeneca | 92,900 |
Sanofi | 82,878 |
Novartis AG | 75,883 |
Danaher | 63,000 |
Stryker | 53,000 |
ABT News
- 13 days ago - Best Dividend Aristocrats For April 2025 - Seeking Alpha
- 14 days ago - New Late-Breaking Data Reinforce Benefits of Abbott's TriClip™ for People With Leaky Tricuspid Heart Valve - PRNewsWire
- 18 days ago - Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms - PRNewsWire
- 19 days ago - Abbott Hosts Conference Call for First-Quarter Earnings - PRNewsWire
- 21 days ago - Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease - PRNewsWire
- 24 days ago - 2025 Dividend Kings: Strong Run Continues - Seeking Alpha
- 4 weeks ago - Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money Sees - Seeking Alpha
- 5 weeks ago - Strong Earnings Lift Abbott Laboratories Shares - FXEmpire